TherapeuticsMD Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Marlan Walker

Chief executive officer

US$1.0m

Total compensation

CEO salary percentage46.7%
CEO tenure2yrs
CEO ownership0.5%
Management average tenure2yrs
Board average tenure8.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Marlan Walker's remuneration changed compared to TherapeuticsMD's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$4m

Jun 30 2024n/an/a

-US$5m

Mar 31 2024n/an/a

-US$6m

Dec 31 2023US$1mUS$476k

-US$8m

Sep 30 2023n/an/a

US$42m

Jun 30 2023n/an/a

US$29m

Mar 31 2023n/an/a

US$17m

Dec 31 2022US$2mUS$425k

US$1m

Sep 30 2022n/an/a

US$3m

Jun 30 2022n/an/a

-US$30m

Mar 31 2022n/an/a

-US$58m

Dec 31 2021US$2mUS$415k

-US$79m

Compensation vs Market: Marlan's total compensation ($USD1.02M) is above average for companies of similar size in the German market ($USD468.04K).

Compensation vs Earnings: Marlan's compensation has been consistent with company performance over the past year.


CEO

Marlan Walker (49 yo)

2yrs

Tenure

US$1,019,817

Compensation

Mr. Marlan D. Walker, J.D., has been Chief Executive Officer of TherapeuticsMD, Inc since December 2022 and was its General Counsel since March 2016 until 2023. He served as the Secretary of TherapeuticsMD...


Leadership Team

NamePositionTenureCompensationOwnership
Thomas Thompson
Executive Chairman12.6yrsUS$193.75k0.18%
€ 21.4k
Marlan Walker
Chief Executive Officer2yrsUS$1.02m0.54%
€ 65.9k
Joseph Ziegler
Principal Financial & Accounting Officer1.3yrsUS$172.62k0%
€ 0
Douglas Steelman
Vice President of Market Accessno datano datano data

2.0yrs

Average Tenure

50yo

Average Age

Experienced Management: 29TA's management team is considered experienced (2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Thomas Thompson
Executive Chairman12.6yrsUS$193.75k0.18%
€ 21.4k
Gail Naughton
Independent Director4.8yrsUS$111.25k0%
€ 0
Cooper Collins
Independent Director12.8yrsUS$133.25k0.45%
€ 54.8k
Justin Roberts
Independent Director2.3yrsno datano data

8.7yrs

Average Tenure

56.5yo

Average Age

Experienced Board: 29TA's board of directors are considered experienced (8.7 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 15:43
End of Day Share Price 2024/12/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

TherapeuticsMD, Inc. is covered by 18 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John TannerCantor Fitzgerald & Co.
Robert LabickCJS Securities, Inc.
Esther RajaveluDeutsche Bank